Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor
抗癌药物亚胺吡啶酮 ONC201 的药理学表征揭示了其对 D2 多巴胺受体的负变构作用机制
期刊:Molecular Pharmacology
影响因子:3.2
doi:10.1124/molpharm.121.000336
R Benjamin Free, Caroline A Cuoco, Bing Xie, Yoon Namkung, Varun V Prabhu, Blair K A Willette, Marilyn M Day, Marta Sanchez-Soto, J Robert Lane, Stéphane A Laporte, Lei Shi, Joshua E Allen, David R Sibley